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Abstract
Background: Few studies have described patients with foregut dysmotility in inflammatory bowel
disease. The aim of this case series was to evaluate clinical characteristics of 5 patients with
inflammatory bowel disease and symptoms and signs of upper gut dysmotility.
Case presentations: We describe a series of four patients with Crohn's disease and one with
indeterminate colitis who presented with severe symptoms and signs of gastroparesis. We
reviewed medical records of all cases. Gastric emptying of a solid meal was assessed by scintigraphy.
Small bowel enteroclysis, gastroduodenoscopy and colonoscopy with biopsies were performed to
estimate the activity of the disease and to exclude organic obstruction. None of the patients had
any signs of active inflammation or stricture. All of the patients had markedly delayed gastric
emptying with a mean t 1/2 of 234 minutes (range 110–380 minutes; normal values 54–94 minutes).
Conclusion: Clinicians should consider impaired gastric emptying when evaluating patients with
Crohn's disease and severe symptoms of upper gut dysmotility, which cannot be attributed to
active inflammation or organic obstruction of the digestive tract. Symptoms in these patients are
refractory to various therapeutic interventions including tube feeding and gastric surgery.
Background
Crohn's disease is a chronic inflammatory condition of
unknown aetiology, which may involve the whole diges-
tive tract from the oral cavity to the anus. Symptoms indic-
ative of gastroparesis, such as vomiting and bloating do
occur in patients with Crohn's disease, but recurrent and/
or persistent symptoms are rare and most clinicians
attribute them to active inflammation or mechanical
obstruction of the small or large bowel. Though local
inflammation and intestinal obstruction may have impor-
tant effects on gastrointestinal motility, motility studies in
patients with Crohn's disease are scant [1,2]. Some reports
indicate that upper gut motility can be impaired in
patients with inactive Crohn's disease [1,3].
The aim of this case series is to describe clinical character-
istics of five patients (four patients with inactive Crohn's
disease and a single patient with indeterminate colitis)
who had severe symptoms of gastroparesis which could
not be attributed to mechanical obstruction or active
inflammation, but who all had impaired gastric emptying
of solid food.
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Case presentation
The patients were all treated in our institute which is a ter-
tiary referral centre for inflammatory bowel disease (IBD)
in the Netherlands. We identified patients by a search of
the morbidity database of the department of Gastroenter-
ology and Hepatology which includes the ICD-9 diag-
noses of975 patients with Crohn's disease and 821
patients with colitis ulcerosa referred between 1973 and
2004 and by a search of the gastric emptying database
which includes 239 patients who underwent a scinti-
graphic gastric emptying study in our hospital between
1999 and 2004. We selected cases with a diagnosis of IBD
including Crohn's disease and ulcerative colitis who also
had an impaired gastric emptying by matching the two
data bases. We identified four patients with Crohn's dis-
ease and one with indeterminate colitis who were diag-
nosed based upon accepted radiological, endoscopic and
histological criteria [4]. We have reviewed the medical
records of the cases who all had a severe symptoms of
foregut dysmotility.
Because of persistent symptoms of nausea, vomiting and
in some cases weight loss patients were thoroughly evalu-
ated. All patients underwent a small bowel enteroclysis.
None of the patients had signs of active inflammation or
stricture. Colonoscopy with inspection of the terminal
ileum was performed in every patient and biopsy speci-
mens were taken for pathological examination. All
patients underwent an upper gastrointestinal endoscopy
to rule out active Crohn's disease in the upper digestive
tract and intestinal stenosis as cause of the symptoms.
Random biopsies were taken from the gastric antrum and
corpus. We found no mechanical obstruction in any of the
patients and there were no endoscopical or histological
signs of active Crohn's disease. Furthermore there were no
signs of inflammation in the laboratory studies. After hav-
ing ruled out active inflammatory disease gastric empty-
ing was evaluated by a scintigraphy in all patients.
Table 1 summarizes clinical data of all patients. Remarka-
bly all of them were females with a mean age of 38.6 years
at the time of impaired gastric emptying (range 21 – 56
years). The mean duration of the disease was 9.4 years
with a wide range from 2 to 26 years. One patient had
small bowel involvement, in two the disease involved the
small bowel and the colon, and in two it was limited to
the colon. Two of the patients had undergone resection,
colectomy with ileostomy (patient 4) and ileum resection
twice (patient 2). Despite discouragement, three of the
patients were smoking. The mean t 1/2 of gastric emptying
was 234 minutes (range 110–380 minutes).
We describe one of the cases (case1) in more detail. This
was a 19-yr-old female patient with a history of asthma
presented to our outpatient clinic with complaints of
abdominal pain and chronic diarrhea that had been
present for approximately 5 months. She complained of
continuous pain localized in the upper abdomen but she
also had intermittent colic-like pain elicited by food
ingestion, sometimes accompanied by nausea. There was
watery diarrhea with a frequency of up to 10 times a day.
She had anorexia and lost 15 kg of weight in the preceding
5 months. She had been taking diclofenac and she
smoked 4 cigarettes per day.
On physical examination she had normal vital signs. Her
weight was 84 kg with a length of 171 cm. There was a
mild tenderness in the right lower abdomen. Further
examination was not remarkable.
Initial laboratory studies revealed a sedimentation rate of
25 mm in the 1st hr, C-reactive protein of 40 mg/L, albu-
min 37 g/L (normal 36–53 g/L), haemoglobin was 7.8
mmol/L (normal 7.3–9.7 mmol/L), white cell count was
12.1 × 109/L (normal 3.5–11.0 × 109/L) with 75% neu-
trophils and thrombocytes were elevated (480 × 109/L;
normal 120–350 × 109/L). Sigmoidoscopy revealed a
patchy erythema with rectal sparing. Histopathology of
the biopsy specimen showed chronic active inflammation
Table 1: Clinical data of the five patients
P a t i e n t s 12345
D i a g n o s i s C DC DC DC D I C
S e x FFFFF
Age (yr) 21 29 38 56 57
Age at diagnosis (yr) 19 23 28 30 54
BMI (kg/m2) 37,4 33 31,4 22,3 19
Localisation Ileum-Colon Ileum Ileum-Colon Colon Colon
Resection No Ileum × 2 No Colectomy No
Stomy No No No Ileostomy No
Smoking Yes Yes Yes No No
T 1/2 (min) 380 288 220 110 171
CD, Crohn's disease; IC, indeterminate colitis; BMI, body mass indexBMC Gastroenterology 2007, 7:11 http://www.biomedcentral.com/1471-230X/7/11
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without presence of granulomas. Barium examination of
the small bowel demonstrated a narrowing of the distal
ileum with thickening of the wall over a length of 40 cm.
A diagnosis of Crohn's disease with involvement of left
colon and terminal ileum was made and treatment was
started with oral corticosteroids and azathioprine in com-
bination with mesalazine. Because of adverse reaction
(fever) to azathioprine and thereafter mercaptopurine,
tioguanine was prescribed, and well tolerated.
One year and a half after the first presentation she com-
plained of nausea, vomiting, early satiety, weight loss of
15 kg and diarrhea. Laboratory studies now showed no
signs of inflammation. There were no endoscopic signs of
activity of Crohn's disease in colon, terminal ileum or
stomach and duodenum. Biopsy specimens taken from
the gastric antrum, duodenum, terminal ileum and colon
revealed no active inflammation. Small bowel enterocly-
sis showed no stricture and the terminal ileum was now
normal. Gastric emptying with radiolabeled pancake was
severely delayed with a t 1/2 of 200 minutes and 3 months
later with a t 1/2 of 380 minutes.
Tioguanine was stopped because of the remote possibility
that the symptoms were secondary to the drugs, but this
did not ameliorate the symptoms. Because of persistent
foregut dysmotility symptoms nasojejunal feeding was
initiated. Recently she underwent a Roux-Y gastrojejunos-
tomy with introduction of an enterocutaneous jejunal
feeding catheter.
Treatment and prognosis
Patient 1 is the only patient who underwent surgery
because of her foregut dysmotility. The surgical procedure
was recently performed but at present the gastroenteros-
tomy fails to improve her symptoms. Patient 4 was only
treated with oral prokinetics that had a partial effect while
all other patients also received nasogastric 24 hour contin-
uous drip tube feeding. One of these three patients
(patient 3) underwent a percutaneous endoscopic gastros-
tomy tube (PEG) placement, which was removed two
months later for psychological reasons. Despite these
interventions, symptoms of upper gut dysmotility persist
in all patients.
Discussion
This report describes five patients with clinically inactive
inflammatory bowel disease who presented with persist-
ent severe complaints of upper gastrointestinal motility
disorder. All patients had disabling upper gastrointestinal
symptoms with weight loss which in most of the cases led
to invasive treatment including nasogastric tube feeding,
PEG and even gastrojejunostomy with placement of a
jejunostomy catheter.
Reports on delayed gastric emptying in Crohn's disease
are scarce. Annese et al studied gastric emptying in 21
adult patients with nonobstructive Crohn's disease [2].
Gastric emptying was not different from that in healthy
volunteers. Only posthoc analysis revealed impaired gas-
tric emptying in a subgroup of patients who complained
of mild upper gut symptoms such as bloating, early satiety
and abdominal distention and in those with localization
restricted to the colon [2]. Our case series extends these
findings and shows that delayed gastric emptying in inac-
tive Crohn's disease may induce serious upper gut symp-
toms prompting clinicians for elaborate diagnostic
investigations including upper gut endoscopy and assess-
ment of gastric emptying. Our series shows that delayed
gastric emptying is not confined to patients with localiza-
tion restricted to the colon.
Why do patients with Crohn's disease develop symptoms
of foregut dysmotility? It is logical to infer that active
Crohn's disease with accompanying intestinal inflamma-
tion has functional ramifications. Contraction of smooth
muscle from inflamed small intestine derived from
patients with Crohn's disease is abnormal [3]. Distal
motility disturbances due to ileal or colonic inflammation
might subsequently impair gastric emptying, a phenome-
non similar to that in patients with slow transit constipa-
tion [5,6]. Likewise, obstruction of the small bowel or
colon due to Crohn's disease can cause foregut dysmotil-
ity. Moreover, gastric Crohn's disease impairs gastric emp-
tying which can be observed in up to 70% of cases, but
this is more often seen in children as compared to adults
[7-9]. None of patients described in this report had signs
of active disease. Enteroclysis, colonoscopy, endoscopy of
the upper gut with bioptic samples and laboratory studies
were compatible with absence of active inflammation in
all patients.
Two of our patients had a history of intestinal resection.
However, surgical resections are not associated with a det-
rimental effect on gastric emptying in patients with
Crohn's disease [10].
Antroduodenal manometry studies have also shown that
upper gastrointestinal motor disorders occur in up to 74%
of patients with uncomplicated Crohn's disease [1]. We
did not perform an antroduodenal manometry in any of
the patients in this case series.
The explanation for the foregut dysmotility and the
related symptoms of our patients is not clear. It is possible
that there is a minor degree of intestinal fibrosis without
radiological signs of obstruction or inflammation of the
bowel that cannot be detected with standard clinical
methods. On the other hand, the gastrointestinal motility
is regulated by gut hormones, of which peptide YY (PYY)Publish with BioMed Central    and   every 
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is the most prominent member [11]. Circulating PYY
inhibits gastric emptying [12,13]. It has been shown that
patients with Crohn's disease have elevated serum levels
of PYY [14], which could be a possible explanation for
upper gastrointestinal motility disturbance in these
patients. Lastly, Porcher et al [15] reported that interstitial
cells of Cajal were abundant in the small intestine of
patients with Crohn's disease and reasoned that this could
lead to desynchronization of electrical pacemaker activity.
This might be due to invasion of the external muscle lay-
ers by inflammatory cells.
Conclusion
We describe five patients with Crohn's disease who had
no signs of active inflammation but developed severe
symptoms of gastroparesis. It remains to be elucidated
why some patients with inactive Crohn's disease develop
upper gut motor disturbances. According to our experi-
ence these patient will develop persistent symptoms
despite medical treatment. Tube feeding is most often nec-
essary and even bypassing of the stomach seems to be the
only therapeutic possibility in the most extreme cases.
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